Showing results (981-990 of 998) with videos related to
Sort By:
Pageof 100
Annals of Neurology|January 3, 2013
Mutations in KCND3 cause spinocerebellar ataxia type 22Yi-Chung Lee, Alexandra Durr, Karen Majczenko, et al.Plos One|May 15, 2013
Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responsesLi-Xin Wang, Zhen-Yang Mei, Ji-Hao Zhou, et al.Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 29, 2012
[Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia]Li-Li Cai, Yang Yang, Bo Yang, et al.Journal of Immunology Research|November 30, 2019
Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled TrialHong-Yan Wen, Jia Wang, Sheng-Xiao Zhang, et al.Nature|June 25, 2016
A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligaseMary E Matyskiela, Gang Lu, Takumi Ito, et al.Science Advances|July 25, 2025
DNA damage response pathway regulates Nrf2 in response to oxidative stressXiao-You Jiang, Qi-Qiang Guo, Shan-Shan Wang, et al.American Journal of Human Genetics|May 6, 2014
AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 traffickingNiovi Setta-Kaffetzi, Michael A Simpson, Alexander A Navarini, et al.Liver Cancer|October 22, 2024
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for OligoprogressionTsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, et al.The Journal of Surgical Research|April 6, 2013
Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive casesBin-Wei Duan, Shi-Chun Lu, Meng-Long Wang, et al.Pageof 100